IDX
INTEG DIAG FPO [IDX]
Healthcare · ASX Small Cap
$2.3700 +0.4%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical56
Catalyst50
Sentiment50
Fundamental91
Momentum72
Risk Gate27
Get alerts when IDX's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Above-average volume (1.8x) on a green day — buyers stepping up
- Drifting lower — down 4.0% over the last 5 days
- Beating the Small Ords index — relative strength of 1.10, so it's outpacing the pack
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Cash positive / operating cashflow positive
- Low P/S ratio (1.2x)
- Strong revenue growth (+56%)
- EPS estimates revised upward (+10pts)
- CANSLIM I: Institutional ownership (27%)
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +56% — the top line is moving in the right direction
- The bigger volume days are the up days — volume-weighted momentum is positive (0.48%/day)
- Altman Z-Score distress zone (1.37 < 1.81, low-confidence approx)
- Days to cover very high (12.1)
- Beneish M-Score -2.17 (grey zone -2.22 to -1.78): possible earnings manipulation
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Not enough chatter to gauge sentiment — defaulting to neutral
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about IDX
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Update - Dividend/Distribution - IDX
NONE Commencement Date for New MD & CEO
NONE Change of Director's Interest Notice - Toby Hall
Recent ASX Announcements
| 2026-03-25 | Update - Dividend/Distribution - IDX |
| 2026-03-24 | Commencement Date for New MD & CEO PRICE SENSITIVE |
| 2026-03-09 | Change of Director's Interest Notice - Toby Hall |
| 2026-03-08 | Change of Director's Interest Notice - Laura McBain |
| 2026-03-01 | Change of Director's Interest Notice - Kevin Shaw |
Key Metrics
$883.8M
Market Cap
1.1M
Avg Volume
1.8x
Vol Ratio
$2.11 — $3.07
52-Week Range
3.4%
Short Interest
N/A
Cash Runway
2.1%
ROE
1.8%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | neutral | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 91% |
| L | Leader vs Laggard | laggard | RS: -1 |
| I | Institutional Sponsorship | pass | Inst: 28% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #58 of 117 · Sector avg: 46
View all Healthcare signals →Track IDX and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required